Antihypertensive activity of casein-enriched milk fermented by Lactobacillus helveticus

This publication has 36 references indexed in Scilit:

• Cardiovascular Effects of Fermented Milk Containing Angiotensin-Converting Enzyme Inhibitors Evaluated in Permanently Catheterized, Spontaneously Hypertensive Rats
  Applied and Environmental Microbiology, 2002
• Growth of the Bacteriocin-Producing Lactobacillus sakei Strain CTC 494 in MRS Broth Is Strongly Reduced Due to Nutrient Exhaustion: a Nutrient Depletion Model for the Growth of Lactic Acid Bacteria
  Applied and Environmental Microbiology, 2001
• Production of Angiotensin-I-Converting-Enzyme-Inhibitory Peptides in Fermented Milks Started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4
  Applied and Environmental Microbiology, 2000
• Structural Analysis of New Antihypertensive Peptides Derived from Cheese Whey Protein by Proteinase K Digestion
  Journal of Dairy Science, 1998
• Comparison of cell surface proteinase activities within the Lactobacillus genus
  Journal of Dairy Research, 1997
• A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects
  The American Journal of Clinical Nutrition, 1996
• The extracellular PI-type proteinase of Lactococcus lactis hydrolyzes beta-casein into more than one hundred different oligopeptides
  Journal of Bacteriology, 1995
• Effect of Casein and β-Casomorphins on Gastrointestinal Motility in Rats
  The Journal of Nutrition, 1990
• Spectrophotometric Assay Using o-Phthaldialdehyde for Determination of Proteolysis in Milk and Isolated Milk Proteins
  Journal of Dairy Science, 1983
• Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung
  Biochemical Pharmacology, 1971